Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

PDF) Impact of Secukinumab on Patient-Reported Outcomes in the

PDF) Multi-biomarker disease activity score as a predictor of

Treat-to-target in axial spondyloarthritis — what about physical

Sex differences in the effectiveness of first-line tumour necrosis

Endorsement of Definitions of Disease Activity States and

Relationship between disease activity status or clinical response

Performance of 3 Composite Measures for Disease Activity in

Efficacy and safety of upadacitinib in patients with active

IJMS, Free Full-Text

Disease Activity-Guided Stepwise Tapering but Not Discontinuation

Canadian Rheumatology Association Meeting Quebec City Convention